Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021
出 版 商：MarketsandMarkets
出版日期：2016/11/17
頁 數：146頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are the major factors driving the growth of the global respiratory diagnostics market.
Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer lucrative opportunities for players in the respiratory diagnostics market. Rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and expansion of private-sector hospitals to rural areas in various APAC countries are the major factors driving the growth of the respiratory diagnostics market.
The global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.
On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests. However, over the years, advancements in technology have led to the replacement of traditional techniques with molecular diagnostic techniques.
On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.
On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global respiratory diagnostics market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the respiratory diagnostics market for hospital/clinical laboratories. Point-of-care diagnostics and patient self-testing are also expected to contribute to the growth of the respiratory diagnostics market in the forecast period due to the increasing demand for convenient testing processes and quick results.
New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.
Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the respiratory diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the respiratory diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on products offered by the top players in the respiratory diagnostics market
‧ Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the respiratory diagnostics market
‧ Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for respiratory diagnostics products across various regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the respiratory diagnostics market
‧ Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the respiratory diagnostics market
Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer lucrative opportunities for players in the respiratory diagnostics market. Rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and expansion of private-sector hospitals to rural areas in various APAC countries are the major factors driving the growth of the respiratory diagnostics market.
The global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.
On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests. However, over the years, advancements in technology have led to the replacement of traditional techniques with molecular diagnostic techniques.
On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.
On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global respiratory diagnostics market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the respiratory diagnostics market for hospital/clinical laboratories. Point-of-care diagnostics and patient self-testing are also expected to contribute to the growth of the respiratory diagnostics market in the forecast period due to the increasing demand for convenient testing processes and quick results.
New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.
Research Coverage:
From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the respiratory diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the respiratory diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on products offered by the top players in the respiratory diagnostics market
‧ Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the respiratory diagnostics market
‧ Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for respiratory diagnostics products across various regions
‧ Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the respiratory diagnostics market
‧ Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the respiratory diagnostics market
TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 17
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.2.1 KEY DATA FROM SECONDARY SOURCES 24
2.2.2 KEY DATA FROM PRIMARY SOURCES 24
2.2.2.1 Key Industry Insights 25
2.2.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
3.1 CONCLUSION 29
4 PREMIUM INSIGHTS 30
4.1 RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021 30
4.2 RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE 31
4.3 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 32
4.4 RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 32
4.5 RESPIRATORY DIAGNOSTICS MARKET, BY END USER 33
4.6 RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES 36
5.2.1.1 High prevalence of tobacco smoking 37
5.2.1.2 Changing lifestyles 37
5.2.1.3 Urbanization and growing pollution levels 38
5.2.2 RISING GERIATRIC POPULATION 38
5.2.3 TECHNOLOGICAL ADVANCEMENTS 39
5.2.4 MARKET RESTRAINTS 39
5.2.4.1 Reimbursement concerns 39
5.2.4.2 Rising healthcare costs limiting the usage of novel respiratory diagnostic techniques 39
5.2.5 MARKET OPPORTUNITIES 40
5.2.5.1 Growing demand for home care and point-of-care diagnostic devices 40
5.2.5.2 High growth potential in developing Asia-Pacific countries 40
5.2.6 MARKET CHALLENGE 41
5.2.6.1 Lack of awareness and large underdiagnosed and undertreated population 41
6 RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE 42
6.1 INTRODUCTION 43
6.2 INSTRUMENTS & DEVICES 44
6.3 ASSAYS & REAGENTS 45
6.4 SERVICES & SOFTWARE 46
7 RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE 47
7.1 INTRODUCTION 48
7.2 MECHANICAL TESTS 49
7.2.1 PULMONARY FUNCTION TESTS 50
7.2.1.1 Spirometry 50
7.2.1.2 Peak flow test 51
7.3 OSA DIAGNOSTIC TESTS 51
7.4 OTHER TEST TYPES 52
7.5 IMAGING TESTS 53
7.5.1 X-RAY 54
7.5.2 COMPUTED TOMOGRAPHY 54
7.5.3 MAGNETIC RESONANCE IMAGING (MRI) 55
7.5.4 POSITRON EMISSION TOMOGRAPHY (PET) 56
7.5.5 OTHER IMAGING TESTS 56
7.6 TRADITIONAL DIAGNOSTIC TESTS 57
7.6.1 IMMUNODIAGNOSTICS 58
7.6.2 BIOCHEMICAL CHARACTERIZATION 59
7.6.3 MICROSCOPY 60
7.7 MOLECULAR DIAGNOSTIC TESTS 61
7.7.1 PCR 62
7.7.2 NUCLEIC ACID AMPLIFICATION TEST 63
7.7.3 IN SITU HYBRIDIZATION 63
7.7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 64
7.7.5 MICROARRAYS 65
7.7.6 OTHER MOLECULAR DIAGNOSTIC TESTS 66
8 RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE 67
8.1 INTRODUCTION 68
8.2 TUBERCULOSIS 69
8.3 ASTHMA 70
8.4 LUNG CANCER 71
8.5 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 72
8.6 OTHER RESPIRATORY DISEASES 73
9 RESPIRATORY DIAGNOSTICS MARKET, BY END USER 74
9.1 INTRODUCTION 75
9.2 HOSPITAL/CLINICAL LABORATORIES 76
9.3 REFERENCE LABORATORIES 77
9.4 PHYSICIAN OFFICES 78
9.5 OTHER END USERS 79
10 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 80
10.1 INTRODUCTION 81
10.2 NORTH AMERICA 82
10.3 EUROPE 88
10.4 ASIA-PACIFIC 92
10.5 REST OF THE WORLD (ROW) 97
11 COMPETITIVE LANDSCAPE 101
11.1 OVERVIEW 102
11.2 BATTLE FOR MARKET SHARE: PRODUCT & SERVICE LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 103
11.3 PRODUCT & SERVICE LAUNCHES 103
11.4 REGULATORY APPROVALS 104
11.5 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS 105
11.6 ACQUISITIONS 106
11.7 EXPANSIONS 106
12 COMPANY PROFILES 107
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 107
12.2 PHILIPS HEALTHCARE 108
12.3 BECTON, DICKINSON & COMPANY 111
12.4 ABBOTT LABORATORIES 114
12.5 THERMO FISHER SCIENTIFIC INC. 116
12.6 BIOMERIEUX 119
12.7 ALERE INC. 122
12.8 BIO-RAD LABORATORIES, INC. 125
12.9 COSMED 127
12.10 SEEGENE INC. 129
12.11 SDI DIAGNOSTICS 131
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 132
13.1 INSIGHTS OF INDUSTRY EXPERTS 132
13.2 DISCUSSION GUIDE 133
13.3 OTHER DEVELOPMENTS 136
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
13.6 AVAILABLE CUSTOMIZATIONS 142
13.7 RELATED REPORTS 143
13.8 AUTHOR DETAILS 144
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 17
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 MARKET SIZE ESTIMATION 20
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.2.1 KEY DATA FROM SECONDARY SOURCES 24
2.2.2 KEY DATA FROM PRIMARY SOURCES 24
2.2.2.1 Key Industry Insights 25
2.2.3 ASSUMPTIONS FOR THE STUDY 25
3 EXECUTIVE SUMMARY 26
3.1 CONCLUSION 29
4 PREMIUM INSIGHTS 30
4.1 RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021 30
4.2 RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE 31
4.3 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 32
4.4 RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 32
4.5 RESPIRATORY DIAGNOSTICS MARKET, BY END USER 33
4.6 RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 RISING PREVALENCE OF RESPIRATORY DISEASES 36
5.2.1.1 High prevalence of tobacco smoking 37
5.2.1.2 Changing lifestyles 37
5.2.1.3 Urbanization and growing pollution levels 38
5.2.2 RISING GERIATRIC POPULATION 38
5.2.3 TECHNOLOGICAL ADVANCEMENTS 39
5.2.4 MARKET RESTRAINTS 39
5.2.4.1 Reimbursement concerns 39
5.2.4.2 Rising healthcare costs limiting the usage of novel respiratory diagnostic techniques 39
5.2.5 MARKET OPPORTUNITIES 40
5.2.5.1 Growing demand for home care and point-of-care diagnostic devices 40
5.2.5.2 High growth potential in developing Asia-Pacific countries 40
5.2.6 MARKET CHALLENGE 41
5.2.6.1 Lack of awareness and large underdiagnosed and undertreated population 41
6 RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE 42
6.1 INTRODUCTION 43
6.2 INSTRUMENTS & DEVICES 44
6.3 ASSAYS & REAGENTS 45
6.4 SERVICES & SOFTWARE 46
7 RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE 47
7.1 INTRODUCTION 48
7.2 MECHANICAL TESTS 49
7.2.1 PULMONARY FUNCTION TESTS 50
7.2.1.1 Spirometry 50
7.2.1.2 Peak flow test 51
7.3 OSA DIAGNOSTIC TESTS 51
7.4 OTHER TEST TYPES 52
7.5 IMAGING TESTS 53
7.5.1 X-RAY 54
7.5.2 COMPUTED TOMOGRAPHY 54
7.5.3 MAGNETIC RESONANCE IMAGING (MRI) 55
7.5.4 POSITRON EMISSION TOMOGRAPHY (PET) 56
7.5.5 OTHER IMAGING TESTS 56
7.6 TRADITIONAL DIAGNOSTIC TESTS 57
7.6.1 IMMUNODIAGNOSTICS 58
7.6.2 BIOCHEMICAL CHARACTERIZATION 59
7.6.3 MICROSCOPY 60
7.7 MOLECULAR DIAGNOSTIC TESTS 61
7.7.1 PCR 62
7.7.2 NUCLEIC ACID AMPLIFICATION TEST 63
7.7.3 IN SITU HYBRIDIZATION 63
7.7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 64
7.7.5 MICROARRAYS 65
7.7.6 OTHER MOLECULAR DIAGNOSTIC TESTS 66
8 RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE 67
8.1 INTRODUCTION 68
8.2 TUBERCULOSIS 69
8.3 ASTHMA 70
8.4 LUNG CANCER 71
8.5 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 72
8.6 OTHER RESPIRATORY DISEASES 73
9 RESPIRATORY DIAGNOSTICS MARKET, BY END USER 74
9.1 INTRODUCTION 75
9.2 HOSPITAL/CLINICAL LABORATORIES 76
9.3 REFERENCE LABORATORIES 77
9.4 PHYSICIAN OFFICES 78
9.5 OTHER END USERS 79
10 RESPIRATORY DIAGNOSTICS MARKET, BY REGION 80
10.1 INTRODUCTION 81
10.2 NORTH AMERICA 82
10.3 EUROPE 88
10.4 ASIA-PACIFIC 92
10.5 REST OF THE WORLD (ROW) 97
11 COMPETITIVE LANDSCAPE 101
11.1 OVERVIEW 102
11.2 BATTLE FOR MARKET SHARE: PRODUCT & SERVICE LAUNCHES—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS 103
11.3 PRODUCT & SERVICE LAUNCHES 103
11.4 REGULATORY APPROVALS 104
11.5 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS 105
11.6 ACQUISITIONS 106
11.7 EXPANSIONS 106
12 COMPANY PROFILES 107
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 INTRODUCTION 107
12.2 PHILIPS HEALTHCARE 108
12.3 BECTON, DICKINSON & COMPANY 111
12.4 ABBOTT LABORATORIES 114
12.5 THERMO FISHER SCIENTIFIC INC. 116
12.6 BIOMERIEUX 119
12.7 ALERE INC. 122
12.8 BIO-RAD LABORATORIES, INC. 125
12.9 COSMED 127
12.10 SEEGENE INC. 129
12.11 SDI DIAGNOSTICS 131
*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 132
13.1 INSIGHTS OF INDUSTRY EXPERTS 132
13.2 DISCUSSION GUIDE 133
13.3 OTHER DEVELOPMENTS 136
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 140
13.6 AVAILABLE CUSTOMIZATIONS 142
13.7 RELATED REPORTS 143
13.8 AUTHOR DETAILS 144
